1.
Clin Infect Dis
; 33(1): e3-7, 2001 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11389511
RESUMO
From 1997 through 1999, the prevalence of the zidovudine resistance mutation T215Y was 9.7% among pregnant women, and the human immunodeficiency virus type 1 (HIV-1) load in those with resistant virus was higher than that measured in women with wild-type HIV-1. All mutations were noted in women with zidovudine experience, which suggests that monotherapy may not be adequate prophylaxis for vertical transmission of HIV-1 infection in the current era.